Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
34.83B
Market cap34.83B
Price-Earnings ratio
13.72
Price-Earnings ratio13.72
Dividend yield
2.49%
Dividend yield2.49%
Average volume
7.60M
Average volume7.60M
High today
$83.20
High today$83.20
Low today
$82.70
Low today$82.70
Open price
$87.32
Open price$87.32
Volume
31.09K
Volume31.09K
52 Week high
$172.23
52 Week high$172.23
52 Week low
$81.10
52 Week low$81.10

Stock Snapshot

Zoetis(ZTS) stock is priced at $83.00, giving the company a market capitalization of 34.83B. It carries a P/E multiple of 13.72 and pays a dividend yield of 2.5%.

On 2026-05-11, Zoetis(ZTS) stock traded between a low of $82.70 and a high of $83.20. Shares are currently priced at $83.00, which is +0.4% above the low and -0.2% below the high.

The Zoetis(ZTS)'s current trading volume is 31.09K, compared to an average daily volume of 7.6M.

During the past year, Zoetis(ZTS) stock moved between $81.10 at its lowest and $172.23 at its peak.

During the past year, Zoetis(ZTS) stock moved between $81.10 at its lowest and $172.23 at its peak.

ZTS News

Simply Wall St 13h
Why Zoetis Cut 2026 Guidance After Weaker Pet Demand And What It Means Now

In early May 2026, Zoetis Inc. reported first-quarter sales of US$2,262 million, essentially flat net income year on year, and lowered its full-year 2026 revenu...

Why Zoetis Cut 2026 Guidance After Weaker Pet Demand And What It Means Now
Benzinga 23h
Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio?

Wall Street's momentum trade turned brutal for several large-cap names last week as weak earnings, cautious guidance and analyst downgrades sparked heavy sellin...

Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio?
TipRanks 3d
Zoetis price target lowered to $99 from $130 at UBS

UBS lowered the firm’s price target on Zoetis (ZTS) to $99 from $130 and keeps a Neutral rating on the shares. Unlock hedge fund-level data and powerful invest...

Analyst ratings

68%

of 22 ratings
Buy
68.2%
Hold
31.8%
Sell
0%

More ZTS News

Simply Wall St 3d
Zoetis Resets Outlook As U.S. Pet Weakness Pressures Valuation And Growth

Zoetis (NYSE:ZTS) has cut its full year guidance after a sharp downturn in its U.S. companion animal business. Management points to higher price sensitivity am...

Zoetis Resets Outlook As U.S. Pet Weakness Pressures Valuation And Growth
TipRanks 3d
Zoetis Earnings Call Balances Strength And Strain

Zoetis ((ZTS)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful inve...

TipRanks 4d
Morning Movers: Planet Fitness and Zoetis sink after quarterly results

Futures are higher this morning, helped by another sharp decline in oil prices on optimism around a potential U.S.-Iran framework agreement. Crude dropping back...

Nasdaq 4d
Why Zoetis Shares Plummeted Today

Key Points Zoetis delivered sales and adjusted earnings per share growth of 3% and 9%, which was below analysts' expectations. Worse yet, its guidance for 202...

Why Zoetis Shares Plummeted Today
Benzinga 4d
US Pet Care Demand Is Weak - Zoetis Cuts Outlook

The animal health company reported adjusted earnings of $1.53 per share, missing the consensus of $1.61. Sales reached $2.26 billion, missing the consensus of $...

US Pet Care Demand Is Weak - Zoetis Cuts Outlook
Investor's Business Daily 4d
Why Zoetis' Slashed 2026 Guidance Still Appears To Be A 'Heavy Lift'

Zoetis Stock Is In The Doghouse Despite Its Quarterly Beat; Here's Why 2/12/2026 Zoetis beat fourth-quarter views Thursday, but better-than-expected sales came...

Why Zoetis' Slashed 2026 Guidance Still Appears To Be A 'Heavy Lift'
Seeking Alpha 4d
Zoetis cuts 2026 outlook as U.S. sales fall in Q1

Shares of Zoetis (ZTS) fell ~13% in the premarket on Thursday after the veterinary product maker lowered its full-year outlook, citing a challenging first quart...

Zoetis cuts 2026 outlook as U.S. sales fall in Q1

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.